Zangeneh, vitamin C ICU study: 4% lower mortality [p=0.86] https://c19p.org/zangenehc
copied to clipboard
Survival analysis based on body mass index in patients with Covid-19 admitted to the intensive care unit of Amir Al-Momenin Hospital in Arak – 2021
et al., Obesity Medicine, doi:10.1016/j.obmed.2022.100420
Retrospective 193 ICU patients in Iran, showing no significant difference with vitamin C treatment.
|
risk of death, 4.0% lower, HR 0.96, p = 0.86, Cox proportional hazards.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Zangeneh et al., 5/13/2022, retrospective, Iran, Middle East, peer-reviewed, 3 authors.
Contact:
mor.zangene62@gmail.com, touraj1416@gmail.com, a.sharifi1983@gmail.com, a_sharifi@goums.ac.ir.
Late treatment
is less effective
is less effective
zangeneh
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.